FIELD: biotechnology
SUBSTANCE: group of inventions relates to the field of biotechnology, namely to the preparation of the ribonucleoprotein complex CRISPR / Cas and the method for its production. The inventions can be used to identify the genome of the SARS-CoV-2 virus.
EFFECT: inventions ensure the detection of single copies of the SARS-CoV-2 virus RNA.
6 cl, 16 dwg, 5 tbl, 5ex
Title | Year | Author | Number |
---|---|---|---|
CRISPR-CAS14 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764020C1 |
METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 |
|
RU2764022C1 |
METHOD FOR OBTAINING A PREPARATION OF THE CRISPR/Cas 12 RIBONUCLEOPROTEIN COMPLEX AND PREPARATION FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764015C1 |
METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 |
|
RU2764021C1 |
CRISPR-Cas 12 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764023C1 |
METHOD OF OBTAINING A PREPARATION OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR-CAS12 AND A PREPARATION FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) RNA IN ULTRA-LOW CONCENTRATIONS | 2022 |
|
RU2802781C1 |
METHOD OF DETECTION OF RNA OF HEPATITIS C VIRUS GENOTYPES 1B AND 3A IN ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2022 |
|
RU2802079C1 |
CRISPR-CAS12 SYSTEM FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) RNA IN ULTRA-LOW CONCENTRATIONS IN ULTRA-LOW CONCENTRATIONS | 2022 |
|
RU2802783C1 |
METHOD OF PRODUCING A PREPARATION OF A RIBONUCLEOPROTEIN COMPLEX CRISPR-CAS AND A PREPARATION FOR DETECTING HEPATITIS C VIRUS RNA OF GENOTYPES 1B AND 3A IN ULTRA-LOW CONCENTRATIONS | 2022 |
|
RU2799430C1 |
METHOD FOR PRODUCING AN AGENT OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR-Cas12 AND AGENT FOR DETECTING THE DNA OF THE HEPATITIS B VIRUS IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2792891C1 |
Authors
Dates
2022-01-12—Published
2021-09-30—Filed